Erowid References Database
|
Boire RG.
“What should the public be told about the risks of Ecstasy? (2)”.
JAMA. 2002;287(5):585.
|
|
Abstract
Letter complimenting an earlier report, authored by Vastag, concerning the NIDA-sponsored conference on ecstasy.
In Mr Vastag's Medical News & Perspectives story,1 I applaud those ecstasy researchers who are bravely challenging the effectiveness of the antiecstasy scare campaign promoted by the National Institute on Drug Abuse (NIDA). As pointed out by the researchers quoted in the article, ecstasy is a complex drug, and the reasons various people use it are equally complex.
Portraying ecstasy as nothing but a brain deadener is not only inaccurate, it is ineffective and dangerous social policy. With million of young adults saying 'yes' to ecstasy it is NIDA's duty to provide them with complete and accurate information about the drug. The fact that NIDA still does not do so is an artifact of the larger 'war' policy with respect to illegal drugs.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
